Mariana Oncology

Mariana Oncology (formerly known as Curie Therapeutics, Inc.) is a fully integrated next-generation radiopharmaceutical company focused on pioneering a new class of targeted radiopharmaceuticals that are both safe and effective. The company brings together experts in ligand discovery, radiochemistry, radiobiology, and oncology translation and clinical research to build a pipeline spanning a range of solid tumor types. Mariana Oncology radiopharmaceuticals consist of rationally designed conjugates targeting carefully selected biological targets to deliver alpha and beta-emitting radionuclide payloads.